Gadolinium Reduction in Brain Tumor Imaging: A Paradigm Shift in Diagnostic Strategies.
作者信息
Brun-Vergara Maria L, Puac-Polanco Paulo, Nicholas Garth, Sinclair John, Nguyen Thanh B
机构信息
Department of Radiology, The Ottawa Hospital, University of Ottawa, 1053 Carling Ave, Ottawa, ON, Canada K1Y 4E9.
Division of Medical Oncology, The Ottawa Hospital Cancer Center, University of Ottawa, Ottawa, Canada.
出版信息
Radiology. 2024 Aug;312(2):e240653. doi: 10.1148/radiol.240653.
Abstract
摘要
相似文献
1
Gadolinium Reduction in Brain Tumor Imaging: A Paradigm Shift in Diagnostic Strategies.
Radiology. 2024 Aug;312(2):e240653. doi: 10.1148/radiol.240653.
2
Detection of Brain Metastases by Contrast-Enhanced MRI: Comparison of Gadopiclenol and Gadobenate in a Mouse Model.
Invest Radiol. 2024 Feb 1;59(2):131-139. doi: 10.1097/RLI.0000000000001032. Epub 2023 Nov 3.
3
Comparative studies of different gadolinium agents in brain tumors: differences between gadolinium chelates and their possible influence on imaging features.
AJNR Am J Neuroradiol. 2010 Jun;31(6):981-2. doi: 10.3174/ajnr.A2068. Epub 2010 Mar 18.
4
Gadolinium-Enhanced T2 FLAIR Is an Imaging Biomarker of Radiation Necrosis and Tumor Progression in Patients with Brain Metastases.
AJNR Am J Neuroradiol. 2025 Jan 8;46(1):129-135. doi: 10.3174/ajnr.A8431.
5
Quantitative MRI relaxometry in brain tumor needle biopsies: Multimodal comparison with tissue fluorescence, radiology, and neuropathology.
PLoS One. 2025 Jul 7;20(7):e0326765. doi: 10.1371/journal.pone.0326765. eCollection 2025.
6
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.
J Neurooncol. 2022 Jun;158(2):139-165. doi: 10.1007/s11060-021-03853-0. Epub 2021 Oct 25.
7
Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.
Neuroradiology. 2019 May;61(5):535-544. doi: 10.1007/s00234-019-02172-6. Epub 2019 Feb 2.
8
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma.
Int J Nanomedicine. 2020 May 1;15:3057-3070. doi: 10.2147/IJN.S238265. eCollection 2020.
9
Impact of brain tumors and radiotherapy on the presence of gadolinium in the brain after repeated administration of gadolinium-based contrast agents: an experimental study in rats.
Neuroradiology. 2019 Nov;61(11):1273-1280. doi: 10.1007/s00234-019-02256-3. Epub 2019 Jul 11.
10
Detection of lymph node metastases by gadolinium-enhanced magnetic resonance imaging: systematic review and meta-analysis.
J Natl Cancer Inst. 2010 Feb 24;102(4):244-53. doi: 10.1093/jnci/djp514. Epub 2010 Feb 1.
本文引用的文献
1
Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy?
Radiology. 2024 Feb;310(2):e230793. doi: 10.1148/radiol.230793.
2
Glioblastoma and radiotherapy: A multicenter AI study for Survival Predictions from MRI (GRASP study).
Neuro Oncol. 2024 Jun 3;26(6):1138-1151. doi: 10.1093/neuonc/noae017.
3
Is there an optimal MRI surveillance schedule for patients with high-grade glioma after standard-of-care-therapy?
Neuro Oncol. 2021 May 5;23(5):711-712. doi: 10.1093/neuonc/noab053.
4
A Position Statement on the Utility of Interval Imaging in Standard of Care Brain Tumour Management: Defining the Evidence Gap and Opportunities for Future Research.
Front Oncol. 2021 Feb 9;11:620070. doi: 10.3389/fonc.2021.620070. eCollection 2021.
5
Glioblastoma post-operative imaging in neuro-oncology: current UK practice (GIN CUP study).
Eur Radiol. 2021 May;31(5):2933-2943. doi: 10.1007/s00330-020-07387-3. Epub 2020 Nov 5.
6
Radiological assessment schedule for high-grade glioma patients during the surveillance period using parametric modeling.
Neuro Oncol. 2021 May 5;23(5):837-847. doi: 10.1093/neuonc/noaa250.
7
Interval brain imaging for adults with cerebral glioma.
Cochrane Database Syst Rev. 2019 Dec 24;12(12):CD013137. doi: 10.1002/14651858.CD013137.pub2.
Zotero 插件